AKT1 and cancer: The upregulation of cellular transformation, tumor progression, and migration occurs through the hyperactivation of the p-Akt/mTORC1/p70S60K pathway, suggesting that Sestrin2, as their regulator, is a potential therapeutic target in cancer 139.